Searched over 200M research papers
10 papers analyzed
These studies suggest that cancer-related organizations and initiatives focus on public policy development, global health education, screening, early prevention, clinical research, access to quality treatments, public-private partnerships, community-based support, and international collaboration to reduce the cancer burden and disparities.
19 papers analyzed
Cancer survivorship advocacy is a critical area where major cancer-related organizations and coalitions are actively working to influence funding, planning, and implementation of care and services for cancer survivors. These initiatives are particularly significant in the context of health care reform, which offers numerous opportunities for nurses and other healthcare professionals to contribute to public policy development that supports cancer survivors' needs.
The burden of cancer is increasing globally, with a significant impact on low- and middle-income countries (LMICs). To address this, numerous large-scale and innovative initiatives have been launched. These programs focus on expanding resources for health education, increasing awareness of cancer prevention, and implementing evidence-based and culturally relevant screening and early prevention programs. Key initiatives also support clinical research, guideline development, oncology training, and technology transfer, such as access to electronic medical literature. These efforts represent unprecedented cooperation among international agencies, governmental and non-governmental organizations, foundations, scientific societies, local institutions, and industry.
CancerX is a national public-private partnership launched as part of the Cancer Moonshot initiative to accelerate innovation in cancer care. This partnership involves multiple stakeholders, including the Moffitt Cancer Center, the U.S. Department of Health and Human Services, and the Digital Medicine Society. CancerX focuses on three key initiatives: pre-competitive evidence generation, an accelerator program for start-ups, and demonstration projects to pilot novel approaches. These efforts aim to reduce the incidence and burden of cancer through innovative solutions across the continuum of cancer care.
Global cancer consortiums play a vital role in reducing cancer inequities, particularly in LMICs. These consortiums involve collaboration among health ministries, national cancer institutes, non-governmental organizations, the private sector, and patient organizations. Notable participants include the World Bank, the Inter-American Development Bank, and the Global Initiative for Cancer Registries (GICR). These collaborations aim to increase knowledge for cancer prevention and control and improve the ability to plan and evaluate cancer programs in the world's poorest regions.
Community-based initiatives, such as the San Francisco Cancer Initiative (SF CAN), focus on reducing the population burden of cancer through prevention and early detection. SF CAN is a cross-sector collaboration involving the San Francisco Department of Public Health, the University of California, San Francisco, major health systems, and community coalitions. The initiative targets five common cancers—breast, lung, prostate, colorectal, and liver—using proven methods of prevention and detection while addressing known disparities.
Community-based and philanthropic organizations play a crucial role in meeting the needs of cancer patients and caregivers. These organizations provide various services, including information and referral resources, financial assistance, home care, and transportation. They also address personal adjustment to illness and other support needs, highlighting the importance of these organizations in the broader cancer care ecosystem.
Community-based participatory research initiatives aim to reduce cancer disparities by increasing communication and collaboration between community-based organizations (CBOs) and university researchers. These initiatives have shown success in strengthening CBO networks, which can lead to more community-informed cancer research and improved access to cancer services.
The Alliance Against Cancer (ACC) in Italy exemplifies a national network of cancer centers that bridge research and care. ACC promotes high standards of care, personalized and precision medicine, and international partnerships. It focuses on tumor genetic screening programs, clinical trials, and access to innovative drugs, contributing significantly to cancer care improvements in Europe.
World Cancer Research Day (WCRD) is a global initiative aimed at raising awareness and commitment to cancer research. Launched in 2016, WCRD has grown to include 89 organizations and over half a million participants. This initiative underscores the importance of a collaborative research culture to address cancer challenges and accelerate impactful research.
National Cancer Control Committees (NCCC) play a pivotal role in coordinating cancer control efforts at the national level. In Indonesia, the NCCC has successfully partnered with non-governmental organizations to enhance cancer control programs. These partnerships have led to numerous public awareness campaigns, cancer treatment services, and supportive care services, demonstrating the effectiveness of coordinated efforts in cancer control.
Cancer-related organizations and initiatives are essential in addressing the global cancer burden. Through advocacy, innovative partnerships, community-based efforts, and international collaborations, these initiatives work towards improving cancer prevention, detection, treatment, and survivorship. The collective impact of these efforts holds promise for reducing cancer disparities and enhancing the quality of life for cancer patients worldwide.
Most relevant research papers on this topic